128 related articles for article (PubMed ID: 17126974)
1. The effects of olanzapine and fluphenazine on plasma cortisol, prolactin and muscle rigidity in schizophrenic patients: a double blind study.
Jakovljevic M; Pivac N; Mihaljevic-Peles A; Mustapic M; Relja M; Ljubicic D; Marcinko D; Muck-Seler D
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Mar; 31(2):399-402. PubMed ID: 17126974
[TBL] [Abstract][Full Text] [Related]
2. Double-blind, randomized comparison of olanzapine versus fluphenazine in the long-term treatment of schizophrenia.
Dossenbach MR; Folnegovic-Smalc V; Hotujac L; Uglesic B; Tollefson GD; Grundy SL; Friedel P; Jakovljevic MM;
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):311-8. PubMed ID: 14751428
[TBL] [Abstract][Full Text] [Related]
3. The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.
David SR; Taylor CC; Kinon BJ; Breier A
Clin Ther; 2000 Sep; 22(9):1085-96. PubMed ID: 11048906
[TBL] [Abstract][Full Text] [Related]
4. Nocturnal hormone profiles in patients with schizophrenia treated with olanzapine.
Mann K; Rossbach W; Müller MJ; Müller-Siecheneder F; Pott T; Linde I; Dittmann RW; Hiemke C
Psychoneuroendocrinology; 2006 Feb; 31(2):256-64. PubMed ID: 16185814
[TBL] [Abstract][Full Text] [Related]
5. Gender differences in prolactin elevation induced by olanzapine in Japanese drug-naïve schizophrenic patients.
Sawamura K; Suzuki Y; Fukui N; Sugai T; Someya T
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Dec; 30(8):1511-4. PubMed ID: 16824658
[TBL] [Abstract][Full Text] [Related]
6. Clozapine and risperidone in chronic schizophrenia: effects on symptoms, parkinsonian side effects, and neuroendocrine response.
Breier AF; Malhotra AK; Su TP; Pinals DA; Elman I; Adler CM; Lafargue RT; Clifton A; Pickar D
Am J Psychiatry; 1999 Feb; 156(2):294-8. PubMed ID: 9989566
[TBL] [Abstract][Full Text] [Related]
7. [Alterations of gait parameters under external cueing in schizophrenic patients: a switch study].
Putzhammer A; Perfahl M; Pfeiff L; Broll K; Hess L; Ibach B
Psychiatr Prax; 2004 Nov; 31 Suppl 1():S164-6. PubMed ID: 15570541
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of olanzapine, an atypical antipsychotic, in patients with schizophrenia: results of an open-label multicenter study in Japan.
Ishigooka J; Murasaki M; Miura S;
Psychiatry Clin Neurosci; 2001 Aug; 55(4):353-63. PubMed ID: 11442886
[TBL] [Abstract][Full Text] [Related]
9. A randomized double-blind 12-week study of quetiapine, risperidone or fluphenazine on sexual functioning in people with schizophrenia.
Kelly DL; Conley RR
Psychoneuroendocrinology; 2006 Apr; 31(3):340-6. PubMed ID: 16198059
[TBL] [Abstract][Full Text] [Related]
10. Weight gain and prolactin levels in patients on long-term antipsychotic medication: a double-blind comparative trial of haloperidol decanoate and fluphenazine decanoate.
Cookson JC; Kennedy NM; Gribbon D
Int Clin Psychopharmacol; 1986 Jul; 1 Suppl 1():41-51. PubMed ID: 3549879
[TBL] [Abstract][Full Text] [Related]
11. The effect of olanzapine treatment on m-chlorophenylpiperazine-induced hormone release in schizophrenia.
Scheepers FE; Gespen de Wied CC; Kahn RS
J Clin Psychopharmacol; 2001 Dec; 21(6):575-82. PubMed ID: 11763004
[TBL] [Abstract][Full Text] [Related]
12. Intermittent pimozide versus fluphenazine decanoate as maintenance therapy in chronic schizophrenia.
McCreadie RG; Dingwall JM; Wiles DH; Heykants JJ
Br J Psychiatry; 1980 Dec; 137():510-7. PubMed ID: 7011468
[TBL] [Abstract][Full Text] [Related]
13. Combination alprazolam-neuroleptic treatment of the positive and negative symptoms of schizophrenia.
Wolkowitz OM; Pickar D; Doran AR; Breier A; Tarell J; Paul SM
Am J Psychiatry; 1986 Jan; 143(1):85-7. PubMed ID: 2867690
[TBL] [Abstract][Full Text] [Related]
14. Effects of clozapine and fluphenazine treatment on responses to m-chlorophenylpiperazine infusions in schizophrenia.
Owen RR; Gutierrez-Esteinou R; Hsiao J; Hadd K; Benkelfat C; Lawlor BA; Murphy DL; Pickar D
Arch Gen Psychiatry; 1993 Aug; 50(8):636-44. PubMed ID: 8343034
[TBL] [Abstract][Full Text] [Related]
15. Decreased levels of ghrelin, cortisol, and fasting blood sugar, but not n-octanoylated ghrelin, in Japanese schizophrenic inpatients treated with olanzapine.
Tanaka K; Morinobu S; Ichimura M; Asakawa A; Inui A; Hosoda H; Kangawa K; Yamawaki S
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1527-32. PubMed ID: 18571822
[TBL] [Abstract][Full Text] [Related]
16. Correlation of antipsychotic and prolactin concentrations in children and adolescents acutely treated with haloperidol, clozapine, or olanzapine.
Alfaro CL; Wudarsky M; Nicolson R; Gochman P; Sporn A; Lenane M; Rapoport JL
J Child Adolesc Psychopharmacol; 2002; 12(2):83-91. PubMed ID: 12188977
[TBL] [Abstract][Full Text] [Related]
17. Olanzapine shifts the temporal relationship between the daily acrophase of serum prolactin and cortisol concentrations rhythm in healthy men.
Vidarsdottir S; Roelfsema F; Frolich M; Pijl H
Psychoneuroendocrinology; 2009 Jun; 34(5):705-12. PubMed ID: 19131173
[TBL] [Abstract][Full Text] [Related]
18. A comparison of weight change during treatment with olanzapine or aripiprazole: results from a randomized, double-blind study.
McQuade RD; Stock E; Marcus R; Jody D; Gharbia NA; Vanveggel S; Archibald D; Carson WH
J Clin Psychiatry; 2004; 65 Suppl 18():47-56. PubMed ID: 15600384
[TBL] [Abstract][Full Text] [Related]
19. Plasma fluphenazine levels by radioimmunoassay in schizophrenic patients treated with depot injections of fluphenazine decanoate.
Wiles DH; Gelder MG
Adv Biochem Psychopharmacol; 1980; 24():599-602. PubMed ID: 7405678
[No Abstract] [Full Text] [Related]
20. [The plasma prolactin level under fluphenazine treatment (author's transl)].
Hinterhuber H; Platz T; Schwarz S
Wien Med Wochenschr; 1980 Sep; 130(17):566-70. PubMed ID: 7456470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
